December 14, 2024 - 17:24

Hall of Fame wide receiver Randy Moss opened up about his health struggles during an emotional Instagram livestream on Friday. The former NFL star revealed that he is now a "cancer survivor," sharing his journey with fans and followers. Moss expressed gratitude for the support he received throughout his battle, emphasizing the importance of early detection and regular health check-ups.
During the livestream, Moss recounted the challenges he faced and the fears that accompanied his diagnosis. He highlighted how crucial it is for individuals to prioritize their health and seek medical advice when needed. Moss's candid discussion resonated with many viewers, inspiring them to take proactive steps in their own health journeys.
As a beloved figure in the sports community, Moss's story serves as a powerful reminder of resilience and hope. His openness about his experience aims to encourage others to advocate for their health and to never take their well-being for granted.
October 21, 2026 - 01:41
Ebola Case Confirmed in Abuja After Traveler Arrives From UgandaNigeria has confirmed an Ebola case in Abuja after a woman arriving from Uganda tested positive, making the country the latest in the region to report an infection as the outbreak continues to...
October 20, 2026 - 03:18
CIM Holds Annual Health and Benefits Fair for StaffThe California Institution for Men in Chino recently hosted its yearly Employee Health and Benefits Fair, giving staff a chance to learn about the resources available to them and their...
October 19, 2026 - 05:23
Health Officials Push for Flu Vaccinations as Early Cases Rise in Some StatesVirginia health officials are urging residents to get their flu shots as data from other parts of the country points to an early jump in infections this season. So far, only about 10 percent of...
October 18, 2026 - 21:18
VA Doctor Leads National Trial on GLP-1 Drugs for Alcohol Use DisorderA physician at the Philadelphia Veterans Affairs Medical Center is heading a nationwide clinical trial that will examine whether GLP-1 receptor agonists, the class of medications best known for...